Medically reviewed by Doru Paul, MD CD20 is a CD marker—a molecule on the cell surface that can be used to identify and type ...

Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...

Also, the panel consists of five different T cell surface markers for T naïve or memory/effector cell phenotyping: CD45RA, CD45RO, CD27 (long-lasting survival), CD95, and CD62L. Improved workflow ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...

It develops from the abnormal multiplication of T cells ... or molecular markers to further characterize the lymphoma and guide treatment decisions. Accurately diagnosing T-cell lymphoma often ...

Cells of the innate system respond rapidly to molecular patterns shared by a broad array of pathogens. Meanwhile, the adaptive system, consisting of T and B cells, responds more slowly, targeting ...